Literature DB >> 4708156

A dose-response study of resistance of leukemia L1210 to cyclophosphamide.

W D DeWys.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4708156     DOI： 10.1093/jnci/50.3.783

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Development of alkylating agent-resistant human tumor cell lines.

Authors:  B A Teicher; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Relationships between various uses of antineoplastic drug-interaction terms.

Authors:  G L Wampler; W H Carter; E D Campbell; P A Keefe
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.

Authors:  B A Teicher; T S Herman; S A Holden; K N Cathcart
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 4.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.